Prostate-specific antigen and other serum markers : Current concepts from the world health organization second international consultation on prostate cancer
(1999) In Seminars in Urologic Oncology 17(4). p.206-221- Abstract
Serum prostate-specific antigen is credited with dramatic advances in the early detection, screening, and management of men with prostatic carcinoma. There has been more than a twofold increase in the number of men diagnosed during the last decade, and prostate cancer has emerged as the most common non-skin cancer and the second leading cause of cancer death in men. This report summarizes the history and current status of prostate-specific antigen and other serum markers, incorporating consensus opinions from the Second International Consultation on Prostate Cancer held in Paris in June 1999.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/ddacf013-940a-45ac-872f-409f9d5f60c4
- author
- Brawer, M. K. ; Benson, M. C. ; Bostwick, D. G. ; Djavan, B. ; Lilja, H. LU ; Semjonow, A. ; Su, S. and Zhou, Z.
- organization
- publishing date
- 1999
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Diagnosis, Markers, Prostate-specific antigen
- in
- Seminars in Urologic Oncology
- volume
- 17
- issue
- 4
- pages
- 206 - 221
- publisher
- Elsevier
- external identifiers
-
- scopus:0033426835
- pmid:10632122
- ISSN
- 1081-0943
- language
- English
- LU publication?
- yes
- id
- ddacf013-940a-45ac-872f-409f9d5f60c4
- date added to LUP
- 2023-02-10 11:09:38
- date last changed
- 2024-10-03 17:00:50
@article{ddacf013-940a-45ac-872f-409f9d5f60c4, abstract = {{<p>Serum prostate-specific antigen is credited with dramatic advances in the early detection, screening, and management of men with prostatic carcinoma. There has been more than a twofold increase in the number of men diagnosed during the last decade, and prostate cancer has emerged as the most common non-skin cancer and the second leading cause of cancer death in men. This report summarizes the history and current status of prostate-specific antigen and other serum markers, incorporating consensus opinions from the Second International Consultation on Prostate Cancer held in Paris in June 1999.</p>}}, author = {{Brawer, M. K. and Benson, M. C. and Bostwick, D. G. and Djavan, B. and Lilja, H. and Semjonow, A. and Su, S. and Zhou, Z.}}, issn = {{1081-0943}}, keywords = {{Diagnosis; Markers; Prostate-specific antigen}}, language = {{eng}}, number = {{4}}, pages = {{206--221}}, publisher = {{Elsevier}}, series = {{Seminars in Urologic Oncology}}, title = {{Prostate-specific antigen and other serum markers : Current concepts from the world health organization second international consultation on prostate cancer}}, volume = {{17}}, year = {{1999}}, }